Dunggay, Mariz T.

HRN: 21-29-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/03/2022
05/09/2022
IVT
45mg
Q24
Age With Mid Dehydration
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Intra-abdominalFebrile Neutropenia    Compliance to guidelines: Non-compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes